These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8883697)

  • 41. A method to increase the power of multiple testing procedures through sample splitting.
    Rubin D; Dudoit S; van der Laan M
    Stat Appl Genet Mol Biol; 2006; 5():Article19. PubMed ID: 17049030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fletcher's paradox.
    Dammann O; Karmaus W
    Epidemiology; 1992 Nov; 3(6):540-2. PubMed ID: 1420523
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
    Tang H; Foster NR; Grothey A; Ansell SM; Goldberg RM; Sargent DJ
    J Clin Oncol; 2010 Apr; 28(11):1936-41. PubMed ID: 20212253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significance, truth and proof of p values: reminders about common misconceptions regarding null hypothesis significance testing.
    Verdam MG; Oort FJ; Sprangers MA
    Qual Life Res; 2014 Feb; 23(1):5-7. PubMed ID: 23700009
    [No Abstract]   [Full Text] [Related]  

  • 45. Type II (beta) errors in the hand literature: the importance of power.
    Chung KC; Kalliainen LK; Hayward RA
    J Hand Surg Am; 1998 Jan; 23(1):20-5. PubMed ID: 9523949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenging the validity of conclusions based on P-values alone: a critique of contemporary clinical research design and methods.
    Ebramzadeh E; McKellop H; Dorey F; Sarmiento A
    Instr Course Lect; 1994; 43():587-600. PubMed ID: 9097190
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of univariate ranges with a multivariate standard.
    Stamhuis IH; Bezemer PD; Kuik DJ
    J Clin Epidemiol; 1988; 41(4):359-66. PubMed ID: 3351543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding statistical hypothesis tests and power.
    Jones MP; Beath A; Oldmeadow C; Attia JR
    Med J Aust; 2017 Aug; 207(4):148-150. PubMed ID: 28814212
    [No Abstract]   [Full Text] [Related]  

  • 49. Computers in paediatrics. 18. Medical decision making: computer program to calculate sensitivity, specificity, false positive and negative rates, positive and negative predictive values and accuracy of a diagnostic test.
    Yip WC; Tay JS; Ho TF; Wong HB
    J Singapore Paediatr Soc; 1986; 28(1-2):74-8. PubMed ID: 3531721
    [No Abstract]   [Full Text] [Related]  

  • 50. Probability model on the use of sentinel animal monitoring for arbovirus.
    Li X; Rossignol PA
    Epidemiology; 1998 Jul; 9(4):446-51. PubMed ID: 9647911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity and specificity of clinical trials. Randomized v historical controls.
    Sacks HS; Chalmers TC; Smith H
    Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The problem with unadjusted multiple and sequential statistical testing.
    Albers C
    Nat Commun; 2019 Apr; 10(1):1921. PubMed ID: 31015469
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ruling out or ruling in disease with the most sensitive or specific diagnostic test: short cut or wrong turn?
    Boyko EJ
    Med Decis Making; 1994; 14(2):175-9. PubMed ID: 8028470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working group.
    Stone AM; Bushnell W; Denne J; Sargent DJ; Amit O; Chen C; Bailey-Iacona R; Helterbrand J; Williams G;
    Eur J Cancer; 2011 Aug; 47(12):1763-71. PubMed ID: 21435858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determining sample size when assessing mean equivalence.
    Asberg A; Solem KB; Mikkelsen G
    Scand J Clin Lab Invest; 2014 Nov; 74(8):713-5. PubMed ID: 25228313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How often is prep close to the true replication probability?
    Trafimow D; MacDonald JA; Rice S; Clason DL
    Psychol Methods; 2010 Sep; 15(3):300-7. PubMed ID: 20822254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Skin testing with respiratory allergens: which techniques, which extracts, which battery?].
    Piette V; Dhivert-Donnadieu H; Demoly P
    Rev Mal Respir; 2002 Sep; 19(4):529-31. PubMed ID: 12417871
    [No Abstract]   [Full Text] [Related]  

  • 59. [Internal quality control : false-rejections and preliminary period].
    Marquis P
    Ann Biol Clin (Paris); 2001; 59(2):214-8. PubMed ID: 11282527
    [No Abstract]   [Full Text] [Related]  

  • 60. Primer on type I and type II errors.
    Eff Clin Pract; 2001; 4(6):284-5. PubMed ID: 11769303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.